Vasopressors and Inotropes - DRAFT

last authored:
last reviewed:

 

 

Please Note: These resources are unfinished; please rely on other sources for your knowledge as well

 

 

Introduction

Vasopressors and inotropes are sympathetic drugs that are used to support the cardiovascular system during resuscitation and other life-threatening states. Vasopressors cause vasoconstriction, leading to increased Mean Arterial Pressure (MAP), while inotropes increase cardiac contractility. However, many drugs acts as both vasopressors and inotropes through action on various receptors.

 

Given the signficiant physiological impacts of these drugs, they should only be used by health care providers with extensive background knowledge and experience, and under monitored settings.

return to top

 

 

 

Indications

Vasopressors are indicated for a decrease of >30 mmHg from baseline systolic blood pressure or MAP <60 mmHg, when either condition results in end-organ dysfunction secondary to hypoperfusion.

return to top

 

 

 

Background Physiology

There are a number of cardiovascular receptors that are involved in response to vasopressors and inotropes. These are as follows:

 

Alpha-1 adrenergic

location

  • peripheral vasculature

effect

  • increase vascular tone, shunting blood to critical organs

 

Beta-1 adrenergic

location

effect

 

Beta-2 adrenergic

location

  • airways

effect

  • bronchodilation

 

 

Dopamine

location

effect

return to top

 

 

 

Common Medications

The following medications are commonly used as vasopressors or inotropes:

Drug

Actions

Uses

Other

epinephrine

  • alpha agonist
  • beta agonist
  • anaphylaxis (SC, IM)
  • cardiac arrest (IV, IE)
  • symptomatic bradycardia
  • severe hypotension
 

dopamine

  • beta agonist (low doses)
  • alpha agonist (high doses)
  • symptomatic bradycardia (IM)
  • severe hypotension
 

nor-epinephrine

  • alpha agonist
  • weak beta agonist
 

 

phenylephrine

  • alpha agonist
   

vasopressin

  • cardiac arrest (IM)
 

dobutamine

  • heart failure
   

return to top

 

 

 

Guidance on Use

 

return to top

 

 

 

Resources and References

 

return to top